Key Benefits Glycemic Control Stimulates insulin secretion in a glucose-dependent manner Reduces inappropriate glucagon levels Improves insulin sensitivity and beta-cell function Controls both fasting and postprandial glucose Weight Management Reduces appetite and food intake Enhances satiety and reduces cravings Activates thermogenesis through glucagon signaling Supports substantial and sustained fat loss Cardiovascular & Metabolic Health Improves lipid profiles (triglycerides, LDL cholesterol) Potentially reduces cardiovascular risk factors Supports liver fat reduction in metabolic-associated fatty liver disease (MAFLD) Dosage & Administration Formulation: 20mg prefilled disposable injection pen with 3ml cartridge Route: Subcutaneous injection Frequency: Once weekly Recommended Dosage Schedule The 20mg pen allows flexible dosing to meet individual treatment goals in both diabetes and obesity management protocols
Aim for the last rep to be super difficult to complete 3-5 sets
And for a 1 mg/mL vial: Units = (0.5 / 1) x 100 = 50 units
Possible concerns encompass herbdrug interactions (e.g., botanical substances influencing cytochrome P450 enzymes), ocular surface toxicity resulting from extended use of certain extracts or preservatives in formulations, and systemic adverse effects from oral supplementation
Pep allows you to log both injectable GLP-1 medications and oral medications like Rybelsus
The most frequent adverse events in the semaglutide treatment arms were gastrointestinal, although these were mostly transient and mild/moderate in severity
